• Filippo Pacciarini's profile

    • What I do

      I have a BSc in General Science and a BSc in Biology from Universidad Católica of Chile, a PhD in Biotechnologies applied to medical science from the Università degli Studi di Milano (Italy) and a Post-doc in the University of Cambridge (UK). I’m a positive and dedicated professional benefiting from vast scientific knowledge and experience gained by working in multicultural and multidisciplinary academic teams, following different projects like the sudden outbreak of SARS virus and characterizing other virus like HIV and HBV.
      I’m currently working as a Trial Manager at the Medical Research Council in London coordinating laboratories participating in clinical trials for HIV and Cancer patients in Europe, Africa and North America.

    • Affiliations

      Current

      Past

    • Interests

      Viruses, Clinical Trials, Scientific Networks

    • Projects


      Bionexa is a web based Scientific Collaboration Network that through education and active communications with its members aims to promote knowledge and technology transfer between Spanish speaking researchers and the investigators and companies of scientific base that exist in in their home countries.

      Bionexa started from a passionate discussion with Cristian Hernandez-Cuevas in a pub in Cambridge.
      We realised there was a need to re-establish contact with the scientific developments that were taking place in Latin America, and motivated by the strong idea of contributing something back to where we came from we decided to develop a way to help spanish speaking researchers connect with each other. All this in order to promote the scientific development in Latin America through the development of a Virtual Platform of Scientific Collaboration.

      We currently have over 450 members and are working alongside Nature Network to increase the number of Latin American scientists present in NN.

    • Publications

      • Persistent Replication of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) in Human Tubular Kidney Cells Selects for Adaptive Mutations in the Membrane Protein. Journal of virology (2008) (Epub 26 Mar 2008) PubMed ID:(18367528 )

      • Pacciarini F, Ghezzi S, Pinna D, Cima S, Zoppetti G, Oreste P, Poli G, Vicenzi E. Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission. The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 27 (2 Suppl 1) , 5-9 (2004) PubMed ID:(15646059)

      view all

    • Contact

      email:
Sign in

New to Nature Network?
Sign up today!

Search people
Send an invite

Advertisement